| Basics |
Inogen, Inc
Inogen Inc is a medical technology company that develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
|
| IPO Date: |
February 14, 2014 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$188.41M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.94 | 2.09%
|
| Avg Daily Range (30 D): |
$0.14 | 1.93%
|
| Avg Daily Range (90 D): |
$0.17 | 2.16%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.22M |
| Avg Daily Volume (30 D): |
.16M |
| Avg Daily Volume (90 D): |
.17M |
| Trade Size |
| Avg Trade Size (Sh.): |
71 |
| Avg Trade Size (Sh.) (30 D): |
56 |
| Avg Trade Size (Sh.) (90 D): |
57 |
| Institutional Trades |
| Total Inst.Trades: |
2,047 |
| Avg Inst. Trade: |
$2.32M |
| Avg Inst. Trade (30 D): |
$1.19M |
| Avg Inst. Trade (90 D): |
$1.19M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.47M |
| Avg Closing Trade (30 D): |
$1.19M |
| Avg Closing Trade (90 D): |
$1.19M |
| Avg Closing Volume: |
40.76K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-.2
|
$-.15
|
|
Diluted EPS
|
|
$-.2
|
$-.15
|
|
Revenue
|
$
|
$ 92.39M
|
$ 92.28M
|
|
Gross Profit
|
$
|
$ 41.32M
|
$ 41.34M
|
|
Net Income / Loss
|
$
|
$ -5.29M
|
$ -4.15M
|
|
Operating Income / Loss
|
$
|
$ -7.12M
|
$ -6.13M
|
|
Cost of Revenue
|
$
|
$ 51.07M
|
$ 50.94M
|
|
Net Cash Flow
|
$
|
$ 2.5M
|
$ -18.22M
|
|
PE Ratio
|
|
|
|
|
|
|
